SCA
Sippican Capital Advisors Portfolio holdings
AUM
$138M
This Quarter Return
+11.16%
1 Year Return
+17.93%
3 Year Return
+61.72%
5 Year Return
+175.5%
10 Year Return
+300.77%
AUM
$125M
AUM Growth
+$125M
(+15%)
Cap. Flow
+$5.86M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
124
New
13
Increased
48
Reduced
32
Closed
5
Top Buys
| 1 |
Columbia Banking Systems
COLB
|
$822K |
| 2 |
JPMorgan Chase
JPM
|
$821K |
| 3 |
Alerus Financial
ALRS
|
$652K |
| 4 |
MidWestOne Financial Group
MOFG
|
$590K |
| 5 |
Bridgewater Bancshares
BWB
|
$543K |
Top Sells
| 1 |
Organon & Co
OGN
|
$1.72M |
| 2 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$1.33M |
| 3 |
CATC
CAMBRIDGE BANCORP
CATC
|
$1.14M |
| 4 |
3M
MMM
|
$999K |
| 5 |
Viatris
VTRS
|
$715K |
Sector Composition
| 1 | Financials | 32.21% |
| 2 | Healthcare | 16.65% |
| 3 | Energy | 14.44% |
| 4 | Consumer Discretionary | 10.91% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
The Bancorp
TBBK
$3.51B
| $6.39M | 5.02% | 165,805 +3,580 | +2% | +$138K |
|
2
NVR
NVR
$22.4B
| $3.78M | 2.97% | 540 -3 | -0.6% | -$21K |
|
3
Chevron
CVX
$324B
| $3.3M | 2.59% | 22,124 +2,261 | +11% | +$337K |
|
4
Triumph Financial, Inc.
TFIN
$1.46B
| $2.86M | 2.24% | 35,653 +2,008 | +6% | +$161K |
|
5
Lennar Class A
LEN
$34.5B
| $2.74M | 2.15% | 18,388 | – | – |
|
6
Eli Lilly
LLY
$657B
| $2.73M | 2.14% | 4,677 +841 | +22% | +$490K |
|
7
AbbVie
ABBV
$372B
| $2.59M | 2.03% | 16,692 +350 | +2% | +$54.2K |
|
8
Merck
MRK
$210B
| $2.5M | 1.96% | 22,965 +1,732 | +8% | +$189K |
|
9
MGM Resorts International
MGM
$10.8B
| $2.36M | 1.85% | 52,740 +1,275 | +2% | +$57K |
|
10
ConocoPhillips
COP
$124B
| $2.27M | 1.78% | 19,567 +1,117 | +6% | +$130K |
|
11
GE Aerospace
GE
$292B
| $2.27M | 1.78% | 17,748 | – | – |
|
12
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.24M | 1.76% | 6,274 +1,205 | +24% | +$430K |
|
13
Veritex Holdings
VBTX
$1.88B
| $2.08M | 1.63% | 89,300 +19,085 | +27% | +$444K |
|
14
Citigroup
C
$178B
| $2.02M | 1.58% | 39,234 +219 | +0.6% | +$11.3K |
|
|
15
JPMorgan Chase
JPM
$829B
| $2.01M | 1.58% | 11,843 +4,825 | +69% | +$821K |
|
16
Bristol-Myers Squibb
BMY
$96B
| $2M | 1.57% | 39,002 +6,341 | +19% | +$325K |
|
17
Diamondback Energy
FANG
$43.1B
| $1.97M | 1.55% | 12,725 -783 | -6% | -$121K |
|
18
Pfizer
PFE
$141B
| $1.96M | 1.54% | 68,144 +18,657 | +38% | +$537K |
|
19
Iron Mountain
IRM
$27.3B
| $1.87M | 1.47% | 26,687 -90 | -0.3% | -$6.3K |
|
20
T Rowe Price
TROW
$23.6B
| $1.86M | 1.46% | 17,295 +930 | +6% | +$100K |
|
21
Gilead Sciences
GILD
$140B
| $1.72M | 1.35% | 21,288 -180 | -0.8% | -$14.6K |
|
22
Coterra Energy
CTRA
$18.7B
| $1.67M | 1.31% | 65,585 -260 | -0.4% | -$6.64K |
|
23
OneMain Financial
OMF
$7.35B
| $1.64M | 1.29% | 33,304 -95 | -0.3% | -$4.67K |
|
24
DaVita
DVA
$9.85B
| $1.64M | 1.28% | 15,618 +2,496 | +19% | +$261K |
|
25
EOG Resources
EOG
$68.2B
| $1.62M | 1.27% | 13,418 -203 | -1% | -$24.6K |
|